These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10505026)

  • 1. Premalignant breast lesions: role for biological markers in predicting progression to cancer.
    Stoll BA
    Eur J Cancer; 1999 May; 35(5):693-7. PubMed ID: 10505026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and biologic markers of premalignant lesions of human breast.
    Krishnamurthy S; Sneige N
    Adv Anat Pathol; 2002 May; 9(3):185-97. PubMed ID: 11981114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiposity as a risk determinant for postmenopausal breast cancer.
    Stoll BA
    Int J Obes Relat Metab Disord; 2000 May; 24(5):527-33. PubMed ID: 10849571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different proliferative patterns characterize different preinvasive breast lesions.
    Viacava P; Naccarato AG; Bevilacqua G
    J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications.
    Stoll BA
    Ann Oncol; 2002 Feb; 13(2):191-6. PubMed ID: 11885994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.
    Shaaban AM; Sloane JP; West CR; Foster CS
    Am J Pathol; 2002 Feb; 160(2):597-604. PubMed ID: 11839580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogen receptor expression in the normal and pre-cancerous breast.
    Shoker BS; Jarvis C; Sibson DR; Walker C; Sloane JP
    J Pathol; 1999 Jul; 188(3):237-44. PubMed ID: 10419589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2 as a prognostic factor in breast cancer.
    Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
    Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
    Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premalignant and in situ breast disease: biology and clinical implications.
    Arpino G; Laucirica R; Elledge RM
    Ann Intern Med; 2005 Sep; 143(6):446-57. PubMed ID: 16172443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
    Tomaszewska R
    Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a chemoprevention cohort from a population of women at high risk for breast cancer.
    Fabian CJ; Kamel S; Zalles C; Kimler BF
    J Cell Biochem Suppl; 1996; 25():112-22. PubMed ID: 9027607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies.
    Fabris G; Marchetti E; Marzola A; Bagni A; Querzoli P; Nenci I
    J Steroid Biochem; 1987; 27(1-3):171-6. PubMed ID: 3695478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.
    Zagouri F; Sergentanis TN; Zografos GC
    World J Surg Oncol; 2007 May; 5():57. PubMed ID: 17540032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.
    Roger P; Sahla ME; Mäkelä S; Gustafsson JA; Baldet P; Rochefort H
    Cancer Res; 2001 Mar; 61(6):2537-41. PubMed ID: 11289127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the expression of Tn antigen in different types of human breast cancer cells using VVA-B4 lectin.
    Konska G; Guerry M; Caldefie-Chezet F; De Latour M; Guillot J
    Oncol Rep; 2006 Feb; 15(2):305-10. PubMed ID: 16391846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of lesions associated with an increased risk of breast cancer.
    Morrow M; Schnitt SJ; Norton L
    Nat Rev Clin Oncol; 2015 Apr; 12(4):227-38. PubMed ID: 25622978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia.
    Gillett CE; Lee AH; Millis RR; Barnes DM
    J Pathol; 1998 Apr; 184(4):396-400. PubMed ID: 9664905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear cytometric changes in breast carcinogenesis.
    Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
    J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.